CAS: 942195-56-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (R)-Tegoprazan REF: 4Z-T-252017CAS: 942195-56-4 | - - - | To inquire | Thu 05 Dec 24 |
 | (4R)-Tegoprazan REF: TR-T145140CAS: 942195-56-4 | - - - | 24,913.00 € | Tue 14 Jan 25 |
 | (R)-Tegoprazan REF: TM-T72812CAS: 942195-56-4 | - - - | 854.00 €~1,818.00 € | Wed 05 Mar 25 |
Ref: 4Z-T-252017
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
(4R)-Tegoprazan
Controlled ProductCAS:942195-56-4
Formula:
C20H19F2N3O3
Color and Shape:
Neat
Molecular weight:
387.38
Ref: TR-T145140
| 25mg | 24,913.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
(R)-Tegoprazan
CAS:942195-56-4
(R)-Tegoprazan, a benzimidazole derivative, inhibits kidney H+/K+-ATPase (IC50: 98 nM). Potential in GI disease research.
Formula:
C20H19F2N3O3
Color and Shape:
Liquid
Molecular weight:
387.38
Ref: TM-T72812
| 25mg | 854.00 € | ||
| 50mg | 1,110.00 € | ||
| 100mg | 1,818.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
